Two Sigma Advisers’s Medicines Co MDCO Stock Holding History

Two Sigma Advisers’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-211,301	Closed	-$17.9M	–	2661
2019 Q4	$17.9M	Buy	211,301 +158,000	+296%	+$10.5M	0.04%	416
2019 Q3	$2.67M	Buy	53,301 +19,300	+57%	+$770K	0.01%	995
2019 Q2	$1.24M	Buy	+34,001	New	+$1.11M	﹤0.01%	1419
2018 Q3	–	Sell	-13,600	Closed	-$499K	–	2484
2018 Q2	$499K	Buy	+13,600	New	+$442K	﹤0.01%	1925
2015 Q2	–	Sell	-8,501	Closed	-$238K	–	2150
2015 Q1	$238K	Sell	8,501 -13,200	-61%	-$371K	﹤0.01%	1677
2014 Q4	$600K	Buy	+21,701	New	+$538K	﹤0.01%	1481
2014 Q3	–	Sell	-7,101	Closed	-$206K	–	2787
2014 Q2	$206K	Buy	+7,101	New	+$190K	﹤0.01%	2270

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Two Sigma Advisers's MDCO Position: Q1 2020 in Review

Two Sigma Advisers sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 211,301 shares — an estimated $17.9M sold.

Two Sigma Advisers first reported a position in MDCO in Q2 2014 and held it in 7 quarters. The position peaked at $17.9M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Two Sigma Advisers reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Two Sigma Advisers sold 211,301 Medicines Co shares in Q1 2020, an estimated $17.9M.
Two Sigma Advisers first reported a position in Medicines Co in Q2 2014 and held it in 7 quarters.
Two Sigma Advisers's Medicines Co position peaked at $17.9M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Two Sigma Advisers's 13F filing for Q1 2020, filed 15 May 2020.